Renal Cell Carcinoma
From the Journals
Oncologists need to advocate for scarce COVID-19 resources: ASCO
The oncologist treating a patient should not make decisions about resource allocation for that patient, ASCO says.
Feature
ASCO announces its own COVID-19 and cancer registry
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
From the Journals
Cancer prevalence among COVID-19 patients may be higher than previously reported
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
Feature
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
Feature
Conducting cancer trials amid the COVID-19 pandemic
From the Journals
‘Brutal’ plan to restrict palliative radiation during pandemic
New guidelines recommend giving palliative radiotherapy only in oncologic emergencies during the COVID-19 pandemic.
Feature
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
From the Journals
No staff COVID-19 diagnoses after plan at Chinese cancer center
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?